Skip to main content
Log in

A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration

  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Mice administered dexamphetamine (4 mg/kg i.p.) once daily for 20 days displayed an enhanced locomotor response (compared to that of vehicletreated mice) to dexamphetamine when challenged 4 to 16 days but not when challenged 32 days after withdrawal.

In the experiments described a 20-day dexamphetamine administration followed by an 8-day withdrawal period was used. Pimozide or haloperidol not only completely antagonised the enhanced response to dexamphetamine (2 mg/kg i.p.) in dexamphetamine-treated mice, but also antagonised all dexamphetamine-induced stimulation. Reserpine, in contrast, preferentially blocked the difference in the response to dexamphetamine of dexamphetamine-and vehicle-treated mice, without antagonising all the dexamphetamine-induced locomotion. The stimulation produced in dexamphetamine-(but not in vehicle-) treated mice by dexamphetamine was partially blocked by phentolamine, phenoxybenzamine, and propranolol. FLA-63 did not significantly influence the response to dexamphetamine in either group. That a dopaminergic mechanism plays a major role in the enhanced response to dexamphetamine was shown by the significantly greater response in dexamphetamine-treated mice to apomorphine challenge.

The treatment of mice with apomorphine (10 mg/kg/day i.p. for 20 days), produced a greater response to apomorphine challenge in the apomorphine-treated mice than in vehicle-treated mice 8 days after withdrawal.

The data show that with long-term administration both dexamphetamine and apomorphine are able to produce in mice what appear to be supersensitive dopamine receptors. Moreover, the enhanced response to dexamphetamine after withdrawal from long-term dexamphetamine treatment appears to require the presence of reserpine-sensitive amine stores and, to a lesser extent, the presence of unblocked α-adrenergic receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Andén, N.-E.: Pharmacological and anatomical implications of induced abnormal movements with l-Dopa. In: l-Dopa and Parkinsonism, A. Barbeau and F. H. McDowell, eds., pp. 132–143, Philadelphia: Davis 1970

    Google Scholar 

  • Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol. 11, 303–314 (1970)

    Google Scholar 

  • Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–629 (1967)

    Google Scholar 

  • Andén, N.-E., Strömbom, U., Svensson, T. H.: Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.) 29, 289–298 (1973)

    Google Scholar 

  • Barbeau, A.: l-Dopa therapy in parkinson's disease: a critical review of nine years experience. Can. Med. Assoc. J. 101, 59–68 (1969)

    Google Scholar 

  • Baudry, M., Martres, M.-P., Schwartz, J.-C.: Modulation in the sensitivity of noradrenergic receptors in the CNS studied by the responsiveness of the cyclic AMP system. Brain Res. 116, 111–124 (1976)

    Google Scholar 

  • Brodie, B. B., Cho, A. K., Gessa, G. L.: Possible role of p-hydroxynorephedrine in the depletion of norepinephrine induced by d-amphetamine and in tolerance to this drug. In: Amphetamines and related compounds; Proceedings of the Mario Negri Institute for Pharmacological Research, Milan, Italy, E. Costa and S. Garattini, eds., pp. 217–230. New York: Raven Press 1970

    Google Scholar 

  • Burt, D. R., Creese, I., Snyder, S. H.: Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196, 326–328 (1977)

    Google Scholar 

  • Carlsson, A.: Biochemical implications of Dopa-induced actions on the central nervous system, with particular reference to abnormal movements. In: l-Dopa and Parkinsonism, A. Barbeau and F. H. McDowell, eds., pp. 205–213. Philadelphia: Davis 1970a

    Google Scholar 

  • Carlsson, A.: Amphetamine and brain catecholamines. In: Amphetamines and related compounds: Proceedings of the Mario Negri Institute for Pharmacological Research. Milan, Italy, E. Costa, and S. Garattini, eds., pp. 289–300. New York: Raven Press 1970b

    Google Scholar 

  • Carlsson, A.: Dopaminergic autoreceptors. In: Chemical tools in catecholamine research, vol. II, O. Almgren, A. Carlsson, and J. Engel, eds., pp. 219–225. Amsterdam: North-Holland 1975

    Google Scholar 

  • Carlsson, A., Corrodi, H., Florvall, L., Ross, S.: The Swedish Patent Application 17198/1967 (1967)

  • Chiel, H., Yehuda, S., Wurtman, R. J.: Development of tolerance in rats to the hypothermic effects of d-amphetamine and apomorphine. Life Sci. 14, 483–488 (1974)

    Google Scholar 

  • Costentin, J., Protais, P., Schwartz, J.-C.: Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature 257, 405–407 (1975)

    Google Scholar 

  • Dunstan, R., Jackson, D. M.: The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol. Psychopharmacology 48, 105–114 (1976)

    Google Scholar 

  • Ellinwood, E. H.: “Accidental conditioning” with chronic meth-amphetamine intoxication: implication for a theory of drug habituation. Psychopharmacologia (Berl.) 21, 131–138 (1971)

    Google Scholar 

  • Engel, J., Liljeqvist, S., Johannessen, K.: Behavioural effects of long-term treatment with antipsychotic drugs. In: Antipsychotic drugs, pharmacodynamics and pharmacokimetics, Y. Zotterman, B. Uvnäs, and G. Sedvall, eds., pp. 63–71. New York: Pergamon Press 1976

    Google Scholar 

  • Fjalland, B., Møller-Nielsen, I.: Enhancement of methylphenidateinduced stereotypies by repeated administration of neuroleptics. Psychopharmacologia (Berl.) 34, 105–109 (1974)

    Google Scholar 

  • Herman, Z. S., Trzeciak, H., Chruściel, T. L., Kmieciak-Kolada, K., Drybański, A., Sokola, A.: The influence of prolonged amphetamine treatment and amphetamine withdrawal on brain biogenic amine content and behaviour in the rat. Psychopharmacologia (Berl.) 21, 74–81 (1971)

    Google Scholar 

  • Jackson, D. M.: The involvement of noradrenergic systems in the locomotor activity stimulation in mice produced by β-phenylethylamine. J. Pharm. Pharmacol. 26, 651–654 (1974)

    Google Scholar 

  • Jackson, D. M., Andén, N.-E., Engel, J., Liljeqvist, S.: The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum. Psychopharmacologia (Berl.) 45, 151–155 (1975a)

    Google Scholar 

  • Jackson, D. M., Dunstan, R., Bracs, P. U.: Pharmacological models in tardive dyskinesia: a role for dopamine and noradrenaline? In: Drugs and psychiatry, G. F. S. Johnson, ed., pp. 13–21. Geigy Psychiatric Symposium, Sydney 1975b

  • Jacobsen, E.: Tranquillisers and sedatives. In: Evaluationof drug activities, pharmacometrics, vol. I, D. R. Laurence and A. L. Bacharach, eds., pp. 215–237. London: Academic Press 1964

    Google Scholar 

  • Klawans, H. L., Crossett, P., Dana, N.: Effect of chronic amphetamine exposure on stereotyped behaviour: implications for pathogenesis of l-Dopa-induced dyskinesias. In: Advances in neurology, Vol. 9, D. B. Calne, T. N. Chase, and A. Barbeau, eds., pp. 105–112. New York: Raven Press 1975b

    Google Scholar 

  • Klawans, H. L., Margolin, D. I.: Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Arch. Gen. Psychiatry 32, 725–732 (1975)

    Google Scholar 

  • Klawans, H. L., Margolin, D. I., Dana, N., Crossett, D.: Supersensitivity of d-amphetamine and apomorphine-induced stereotyped behaviour induced by chronic d-amphetamine administration. J. Neurol. Sci. 25, 283–289 (1975a)

    Google Scholar 

  • Klawans, H. L., Rubovits, R.: An experimental model of tardive dyskinesia. J. Neurol. Trans. 33, 235–246 (1972)

    Google Scholar 

  • Lewander, T.: Urinary excretion and tissue levels of catecholamines during chronic amphetamine intoxication. Psychopharmacologia (Berl.) 13, 394–407 (1968)

    Google Scholar 

  • Lewander, T.: Effects of acute and chronic amphetamine intoxication on brain catecholamines in the guinea pig. Acta Pharmacol. Toxicol. 29, 209–225 (1971)

    Google Scholar 

  • Markham, C. H.: The choreoathetoid movement disorder induced by levodopa. Clin. Pharmacol. Ther. 12, 340–346 (1971)

    Google Scholar 

  • Moore, K. E., Dominic, J. A.: Tyrosine hydroxylase inhibitors. Fed. Proc. 30, 859–870 (1971)

    Google Scholar 

  • Overstreet, D. H., Kozar, M. D., Lynch, G. S.: Reduced hypothermic effects of cholinomimetic agents following chronic anticholinesterase treatment. Neuropharmacol. 12, 1017–1032 (1973)

    Google Scholar 

  • Peachy, J. E., Rogers, B., Brien, J. F.: A comparative study of the behavioural responses induced by chronic administration of methamphetamine and amphetamine in mice. Psychopharmacology 51, 137–140 (1977)

    Google Scholar 

  • Rylander, G.: Psychoses and the punding and choreiform syndromes in addition to central stimulant drugs. Psychiatr. Neurol. Neurochir. 75, 203–213 (1972)

    Google Scholar 

  • Sahakian, B. J., Robbins, T. W., Iversen, S. D.: α-Flupenthixol induced hyperactivity by chronic dosing in rats. Eur. J. Pharmacol. 37, 169–178 (1976)

    Google Scholar 

  • Schelkunov, E. L.: Adrenergic effect of chronic administration of neuroleptics. Nature (Lond.) 214, 1210–1212 (1967)

    Google Scholar 

  • Segal, D. S., Mandell, A. J.: Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2, 249–255 (1974)

    Google Scholar 

  • Smith, R. L., Dring, L. G.: Patterns of metabolism of β-phenylisopropylamines in man and other species. In: Amphetamines and related compounds; Proceedings of the Mario Negri Institute for Pharmacological Research, Milan, Italy, E. Costa and S. Garattini, eds., pp. 121–139. New York: Raven Press 1970

    Google Scholar 

  • Svensson, T. H.: Functional and biochemical effects of d-and l-amphetamine on central catecholamine neurons. Naunyn-Schmiedebergs Arch. Pharmacol. 271, 170–180 (1971a)

    Google Scholar 

  • Svensson, T. H.: The effect of inhibition of catcholamines in motor activity. M.D. thesis, Göteborgs Universitet (1971b)

  • Strömbom, U.: Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn Schmiedebergs Arch. Pharmacol. 292, 167–176 (1976)

    Google Scholar 

  • Tarsy, D., Baldessarini, R. J.: Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology 13, 927–940 (1974)

    Google Scholar 

  • Ungerstedt, U.: Postsynaptic supersensitivity after 6-OH-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. [Suppl.] 367, 69–93 (1971)

    Google Scholar 

  • Weissman, A., Koe, B. K., Tenen, S. S.: Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 151, 339–352 (1966)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bailey, R.C., Jackson, D.M. A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration. Psychopharmacology 56, 317–326 (1978). https://doi.org/10.1007/BF00432856

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00432856

Key words

Navigation